Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
$1.22
$1.36
$1.03
$2.98
$100.37M1.433.57 million shs4.86 million shs
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$42.60
+1.8%
$52.58
$39.61
$151.41
$1.21B0.831.37 million shs1.02 million shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$63.77
+0.2%
$67.25
$59.74
$100.05
$3.80B0.58940,462 shs523,632 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
-6.15%-14.69%+2.52%-25.15%-40.49%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
+4.37%-3.60%-27.42%-30.87%-72.62%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
+3.72%+5.52%-10.28%-22.00%-35.61%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
$1.22
$1.36
$1.03
$2.98
$100.37M1.433.57 million shs4.86 million shs
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$42.60
+1.8%
$52.58
$39.61
$151.41
$1.21B0.831.37 million shs1.02 million shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$63.77
+0.2%
$67.25
$59.74
$100.05
$3.80B0.58940,462 shs523,632 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
-6.15%-14.69%+2.52%-25.15%-40.49%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
+4.37%-3.60%-27.42%-30.87%-72.62%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
+3.72%+5.52%-10.28%-22.00%-35.61%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
2.43
Hold$4.50268.85% Upside
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.10
Hold$85.0099.53% Upside
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
2.64
Moderate Buy$92.8045.52% Upside

Current Analyst Ratings Breakdown

Latest INSP, MMSI, and INO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/13/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
DowngradeHoldStrong Sell
5/8/2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
DowngradeHold (C-)Sell (D+)
5/7/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Reiterated RatingMarket Perform
5/6/2026
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
DowngradeSell (D-)Sell (E+)
5/6/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
DowngradeSell (D+)Sell (D)
5/5/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Lower Price TargetSector Perform$56.00 ➝ $45.00
5/5/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Set Price Target$55.00
5/5/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
DowngradeOverweightNeutral$85.00 ➝ $55.00
5/5/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Lower Price TargetNeutral$67.00 ➝ $54.00
5/5/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Lower Price TargetBuy$70.00 ➝ $65.00
5/5/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Lower Price TargetHold$64.00 ➝ $50.00
(Data available from 5/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
$60K1,672.82N/AN/A$0.07 per share17.43
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$911.98M1.35$2.92 per share14.61$27.50 per share1.55
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$1.52B2.51$5.89 per share10.82$27.27 per share2.34
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
-$84.95M-$1.45N/AN/AN/AN/A-489.79%-95.40%N/A
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$145.42M$4.499.4928.984.3214.33%10.35%8.81%8/3/2026 (Estimated)
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$128.49M$2.3127.6116.191.989.03%13.54%7.94%7/29/2026 (Estimated)

Latest INSP, MMSI, and INO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2026Q1 2026
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
-$0.30-$0.28+$0.02-$0.28$0.33 millionN/A
5/4/2026Q1 2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-$0.2753$0.10+$0.3753-$0.39$200.04 million$204.58 million
4/30/2026Q1 2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.84$0.94+$0.10$0.68$377.59 million$381.88 million
3/12/2026Q4 2025
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
-$0.37$0.31+$0.68$0.31$0.33 millionN/A
2/24/2026Q4 2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.96$1.04+$0.08$0.63$390.77 million$393.94 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
N/AN/AN/AN/AN/A
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/AN/AN/AN/AN/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
N/A
1.04
1.04
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/A
6.34
4.48
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.45
5.08
3.46

Institutional Ownership

CompanyInstitutional Ownership
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
26.79%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
94.91%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
99.66%

Insider Ownership

CompanyInsider Ownership
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
1.70%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.20%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
32082.27 million80.87 millionOptionable
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
1,33328.81 million28.18 millionOptionable
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
7,50059.65 million59.24 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Inovio Pharmaceuticals stock logo

Inovio Pharmaceuticals NASDAQ:INO

$1.22 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.25 +0.03 (+2.13%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

Inspire Medical Systems stock logo

Inspire Medical Systems NYSE:INSP

$42.60 +0.77 (+1.84%)
Closing price 03:59 PM Eastern
Extended Trading
$42.30 -0.30 (-0.71%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Merit Medical Systems stock logo

Merit Medical Systems NASDAQ:MMSI

$63.77 +0.13 (+0.20%)
Closing price 04:00 PM Eastern
Extended Trading
$63.80 +0.03 (+0.05%)
As of 04:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.